The Long-Term Effects of Teprotumumab Treatment on Thyroid Eye Disease
A recent study presented at ENDO 2024, the annual conference of the Endocrine Society in Boston, and published in the prestigious journal Thyroid, revealed promising results for individuals suffering from thyroid eye disease after undergoing teprotumumab treatment.
Exploring the Complexity of Thyroid Eye Disease
Thyroid eye disease, a chronic autoimmune condition, tends to worsen over time despite various treatment options. Dr. George Kahaly, a prominent figure in the field of endocrinology, emphasized the importance of ongoing management for patients dealing with this condition.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
